Literature DB >> 12941881

Ebola virus pathogenesis: implications for vaccines and therapies.

Nancy Sullivan1, Zhi-Yong Yang, Gary J Nabel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12941881      PMCID： PMC224575          DOI： 10.1128/jvi.77.18.9733-9737.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  50 in total

1.  Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils.

Authors:  A L Kindzelskii; Z Yang; G J Nabel; R F Todd; H R Petty
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

2.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Authors:  J M Kilby; S Hopkins; T M Venetta; B DiMassimo; G A Cloud; J Y Lee; L Alldredge; E Hunter; D Lambert; D Bolognesi; T Matthews; M R Johnson; M A Nowak; G M Shaw; M S Saag
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 3.  Filovirus diseases.

Authors:  C J Peters; A S Khan
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

4.  Histopathological and immunohistochemical studies of lesions associated with Ebola virus in a naturally infected chimpanzee.

Authors:  M Wyers; P Formenty; Y Cherel; L Guigand; B Fernandez; C Boesch; B Le Guenno
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  S R Zaki; W J Shieh; P W Greer; C S Goldsmith; T Ferebee; J Katshitshi; F K Tshioko; M A Bwaka; R Swanepoel; P Calain; A S Khan; E Lloyd; P E Rollin; T G Ksiazek; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; M C Georges-Courbot; M Capron; J Lansoud-Soukate; P Debré; S P Fisher-Hoch; J B McCormick; A J Georges
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

7.  Development of a preventive vaccine for Ebola virus infection in primates.

Authors:  N J Sullivan; A Sanchez; P E Rollin; Z Y Yang; G J Nabel
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

8.  Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.

Authors:  V N Malashkevich; B J Schneider; M L McNally; M A Milhollen; J X Pang; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Pathogenesis of experimental Ebola virus infection in guinea pigs.

Authors:  B M Connolly; K E Steele; K J Davis; T W Geisbert; W M Kell; N K Jaax; P B Jahrling
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

10.  Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.

Authors:  F Villinger; P E Rollin; S S Brar; N F Chikkala; J Winter; J B Sundstrom; S R Zaki; R Swanepoel; A A Ansari; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226
View more
  52 in total

Review 1.  Clinical development of Ebola vaccines.

Authors:  Saranya Sridhar
Journal:  Ther Adv Vaccines       Date:  2015-09

2.  Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.

Authors:  Sven Verdonck; Szu-Yuan Pu; Fiona J Sorrell; Jon M Elkins; Mathy Froeyen; Ling-Jie Gao; Laura I Prugar; Danielle E Dorosky; Jennifer M Brannan; Rina Barouch-Bentov; Stefan Knapp; John M Dye; Piet Herdewijn; Shirit Einav; Steven De Jonghe
Journal:  J Med Chem       Date:  2019-06-12       Impact factor: 7.446

3.  Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.

Authors:  Reed F Johnson; Sarah E McCarthy; Peter J Godlewski; Ronald N Harty
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

5.  How Ebola impacts genetics of Western lowland gorilla populations.

Authors:  Pascaline J Le Gouar; Dominique Vallet; Laetitia David; Magdalena Bermejo; Sylvain Gatti; Florence Levréro; Eric J Petit; Nelly Ménard
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

6.  Successful delivery of RRT in Ebola virus disease.

Authors:  Michael J Connor; Colleen Kraft; Aneesh K Mehta; Jay B Varkey; G Marshall Lyon; Ian Crozier; Ute Ströher; Bruce S Ribner; Harold A Franch
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

7.  Point/counterpoint. Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus.

Authors:  Wilfred F Ngwa; Roland Teboh; Colin G Orton
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

8.  Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.

Authors:  James E Strong; Gary Wong; Shane E Jones; Allen Grolla; Steven Theriault; Gary P Kobinger; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

9.  Inhibition of Ebola Virus Infection: Identification of Niemann-Pick C1 as the Target by Optimization of a Chemical Probe.

Authors:  Kyungae Lee; Tao Ren; Marceline Côté; Berahman Gholamreza; John Misasi; Anna Bruchez; James Cunningham
Journal:  ACS Med Chem Lett       Date:  2012-12-19       Impact factor: 4.345

10.  Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.

Authors:  Kathrina Quinn; Melinda A Brindley; Melodie L Weller; Nikola Kaludov; Andrew Kondratowicz; Catherine L Hunt; Patrick L Sinn; Paul B McCray; Colleen S Stein; Beverly L Davidson; Ramon Flick; Robert Mandell; William Staplin; Wendy Maury; John A Chiorini
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.